OxyContin maker cuts sales staff, won’t hawk drug to docs
The decision by OxyContin maker Purdue Pharma to stop encouraging physicians to write the painkiller's scripts is drawing positive reviews from opioid experts who caution that far more work must be done to crush the killer epidemic. Purdue said it is slashing its sales staff and will halt, effective Monday, promoting the drug to health care professionals. The decision comes...
more
